Arcus Biosciences
Andrew Pennell has a background in chemistry and pharmaceutical development. With experience in companies like Arcus Biosciences, ChemoCentryx, Genesoft Inc., and Glaxo Wellcome, Andrew has held various leadership roles in medicinal chemistry and drug development. Andrew's expertise includes working on cancer immunotherapies, autoimmune diseases, inflammatory disorders, and infectious diseases. Andrew also has a PhD in Organic Chemistry from Imperial College London.
This person is not in the org chart
This person is not in any offices
Arcus Biosciences
3 followers
Arcus Biosciences is a company creating new cancer therapeutics through the utilization of emerging insights in immunology. Arcus was formed in 2015 by a group of researchers from the biotechnology and pharmaceutical industries.